Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability-Reference-Cited by-同舟云学术

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability

Published:2020-09 Issue: Volume:18 Page:476-490
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Kennedy Edward M.,Farkaly Terry,Grzesik Peter,Lee Jennifer,Denslow Agnieszka,Hewett Jacqueline,Bryant Jeffrey,Behara Prajna,Goshert Caitlin,Wambua Daniel,De Almeida Ana,Jacques Judith,Deavall Damian,Rottman James B.,Glorioso Joseph C.,Finer Mitchell H.,Haines Brian B.,Quéva Christophe,Lerner Lorena

Funder

Oncorus, Inc

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference41 articles.

1. A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers;Diallo;Mol. Ther.,2010

2. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus;Felt;J. Virol.,2017

3. Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy;Liu;Sci. Rep.,2013

4. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling;Moerdyk-Schauwecker;Virology,2013

5. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas;Mineta;Nat. Med.,1995

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

2. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy;Frontiers in Immunology;2024-03-21

3. Methods of miRNA delivery and possibilities of their application in neuro-oncology;Non-coding RNA Research;2023-12

4. Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment;Molecular Therapy - Oncolytics;2023-12

5. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells;Frontiers in Cellular and Infection Microbiology;2023-05-31